Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043017 · ClinicalTrials.gov registry record · Phase 2
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
A Phase 2 study, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- Phase 2
- Development phase
- 356
- Enrollment target
NCT00043017: Completed Phase 2 study, sponsored by American College of Radiology Imaging Network.
NCT00043017 is a Phase 2 study that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 356 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (168% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00043017, a Phase 2 study, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 356 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may help determine the effectiveness of chemotherapy in killing breast cancer and allow doctors to plan more effective treatment. PURPOSE: Diagnostic trial to study the effectiveness of MRI in monitoring tumor response in women who are receiving chemotherapy for stage III breast cancer.
Interventions
- RADIATION gadopentetate dimeglumine
- PROCEDURE MRI/MRS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2002-05 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
What the finished NCT00043017 record still lists
NCT00043017 is an interventional study that assigns participants to a tested intervention. The registered 356 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (168% higher).
The record links to 0 conditions, and to 2 interventions - of which gadopentetate dimeglumine is the first listed.
NCT00043017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00043017 about?
NCT00043017 is a clinical study titled "Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer". RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may help determine the effectiveness of chemotherapy in killing breast cancer and allow doctors to plan more effective treatment. PURPOSE: Diagnostic trial to study the effectiveness of MRI in monitoring tumor response in wom...
What is the current status of trial NCT00043017?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 356 participants. The study started on 2002-05. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00043017?
The interventions under investigation include: gadopentetate dimeglumine (RADIATION), MRI/MRS (PROCEDURE).
Who is sponsoring clinical trial NCT00043017?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00043017's enrollment target sits among peer trials
356 128th of 2000 higher than 1,873 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
- NCT06958328 · 356 participants · Phase 3
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- NCT06960993 · 356 participants · NA
Mosaic Trial for Stem Cell Transplant Recipients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia